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INTRODUCTION
Stress-induced cardiomyopathy (SCMP), also known as 
apical ballooning syndrome or Takotsubo cardiomyop-
athy, is a cardiac syndrome characterized by transient 
left ventricular dysfunction that can mimic acute myo-
cardial infarction (AMI) without obstructive coronary 
artery disease [1-3]. Almost two thirds of patients with 
SCMP experience an emotionally or physically stress-
ful event [3,4] which immediately precedes the cardiac 
event. SCMP is associated with regional wall motion 
abnormalities involving hypokinesia or akinesia of the 
mid and apical segments of the left ventricle, and these 
wall motion abnormalities typically resolve themselves 
within several days [5]. 
Previous reports have demonstrated that patients 
with SCMP have various abnormalities in their elec-
trocardiogram (ECG) such as ST-segment elevation, T 
wave inversion, nonspecific ST-T abnormalities, and 
prolongation of the corrected QT (QTc) interval [6-8]. 
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Background/Aims: Although transient changes in the electrocardiogram (ECG) 
of patients with stress-induced cardiomyopathy (SCMP) are common, there are 
little data about ECG changes in patients with SCMP and the clinical implica-
tions of these variations.
Methods: We investigated a total of 128 patients (age, 63.2 ± 15.4 years; female, 
60.9%) diagnosed with SCMP. We compared the ECGs taken after SCMP diag-
nosis and during the recovery phase to those taken before SCMP diagnosis un-
der baseline conditions. All patients were divided into two groups according to 
corrected QT (QTc) interval changes: recovered QTc group (QTc in SCMP > QTc 
in recovery phase, n = 77) and nonrecovered QTc group (QTc in SCMP ≤ QTc in 
recovery phase, n = 51). 
Results: In comparison of baseline, SCMP, and recovery phase, we found the 
mean heart rate (81.5 ± 18.7, 96.8 ± 25.3, and 83.0 ± 19.4/min, respectively; p < 0.001), 
frequencies of ST segment elevation (0.0%, 8.6%, and 1.6%, p = 0.004), ST seg-
ment depression (0.0%, 6.3%, and 1.6%, p = 0.007), T wave inversion (4.4 %, 43.8%, 
and 61.7%, p < 0.001), and QTc (447.4 ± 35.3, 488.9 ± 67.1, and 468.0 ± 49.5, p < 0.001) 
showed significant changes. In-hospital mortality (9.1% vs. 25.5%, p = 0.012) and 
critical care (54.5% vs. 72.5%, p = 0.040) occurred more frequently in the nonre-
covered QTc group than in recovered QTc group. 
Conclusions: The QTc can be prolonged in patients with SCMP. Short-term 
mortality was increased in patients where the QTc did not recover.
Keywords: Takotsubo cardiomyopathy; QTc interval; Electrocardiography; Mortality
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Critically, repolarization dispersion, such as the prolon-
gation of QTc interval, was also seen in the acute and 
subacute phases of SCMP [9]. The QTc interval is longer 
in SCMP than in AMI, and typically resolves over 3 to 4 
months [9,10]. The prolonged QTc intervals are at risk 
of ventricular arrhythmia, such as polymorphic ventric-
ular tachycardia, in patients with acute phase of SCMP 
[11-13]. Although these transient electrocardiographic 
changes are common features in patients with SCMP, 
there are little data about the serial electrocardiographic 
changes in patients with SCMP during hospitalization. 
Furthermore, the clinical implications of the QTc inter-
val prolongation in SCMP patients have not been fully 
investigated. Therefore, the aim of this study is to inves-
tigate the clinical significance of QTc interval changes 
in patients with SCMP.
METHODS 
Study design and patient selection
We retrospectively analyzed the clinical data of 429 pa-
tients with a clinical diagnosis of SCMP between Feb-
ruary 2009 and March 2014 at a single university hospi-
tal. We excluded patients with atypical ballooning types 
(transient hypokinesis, akinesis, or dyskinesis of the left 
ventricular mid segments without apical involvement), 
structural heart disease, and regional wall motional ab-
normalities that were not recovered. Our study popula-
tion consisted of 128 patients who had typical apical bal-
looning with no lasting wall motion abnormalities. The 
Institutional Review Board of Severance Cardiovascular 
Hospital waived the requirement for informed consent 
for this retrospective analysis. Fig. 1 outlines the patient 
selection process. 
Diagnosis of SCMP
All patients fulfilled the Mayo Clinic criteria for SCMP 
[1,14], and follow-up echocardiograms demonstrated 
complete resolution of the left ventricular dysfunction. 
We categorized the time course of SCMP as the base-
line phase, the SCMP diagnosis phase, and the recovery 
phase. Each phase was defined by the following methods: 
(1) the baseline phase was defined as a clinical period be-
fore the presence of any cardiac dysfunction or abnormal 
cardiac events, (2) the SCMP diagnosis phase was defined 
as clinically diagnosed SCMP with the lowest ejection 
fraction (EF) assessed by echocardiogram, and (3) the re-
covery phase was defined as a clinical recovery with fully 
recovered left ventricular function assessed by echocar-
diogram. We evaluated ECG parameters during each of 
these phases. The wall motion score index (WMSI) was 
calculated by the average of all analyzed segment scores.
Electrocardiogram analysis
We evaluated all 128 study subjects’ serial ECGs ac-
cording to their serial echocardiographic findings, and 
we obtained the baseline ECG of 113 patients (88.3%). 
Twelve-lead ECGs were recorded at a paper speed of 25 
mm/sec with a 10 mm/mV amplification scale using the 
GE Marquette MUSE system (GE Medial System, Mil-
waukee, WI, USA). The high and low cut-off frequen-
cies were 100 and 0.5 Hz, respectively. The ECGs were 
simultaneously assessed by two investigators who were 
blinded of clinical characteristics, patients group, and 
in-hospital course. 
We compared the serial ECG changes of each patient 
taking during each phase of their hospitalization: the 
baseline phase, the SCMP diagnosis phase, and the re-
covery phase. We acquired the following ECG param-
eters: heart rate, ST elevation (> 1 mm in at least two 
contiguous leads), ST depression (> 1 mm in at least two 
contiguous leads), and T wave inversion (inverted T wave 
amplitude > 3 mm in at least three precordial or inferior 
leads). The QTc interval (corrected for heart rate accord-
ing to Bazett’s formula, QTc = QT/√RR) was automat-
ically measured. We defined an abnormally prolonged 
Figure 1. Study design and exclusion criteria. SCMP, 
stress-induced cardiomyopathy; RWMA, regional wall-mo-
tion abnormality; QTc, corrected QT.
429 Suspicious SCMP
301 Excluded patients
       - Atypical
       - Structural heart disease
       - Not recovered RWMA
128 Typical apical ballooning, 
fully recovered
QTc in SCMP > QTc in recovery QTc in SCMP ≤ QTc in recovery
77 Recovered QTc 51 Nonrecovered QTc
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QTc interval as > 450 ms in men and > 470 ms in women 
[15]. All patients were divided into two groups according 
to QTc interval changes: (1) recovered QTc group (QTc 
in SCMP > QTc in recovery phase, n = 77), or (2) nonre-
covered QTc group (QTc in SCMP ≤ QTc in recovery 
phase, n = 51). We excluded QTc prolongation that was 
induced by drugs and electrolyte imbalance.
Study endpoints
The primary endpoint was in-hospital all-cause mortal-
ity after study patients were diagnosed with SCMP. The 
secondary endpoints were incidences of critical care af-
ter SCMP diagnosis and the length of hospital stay. Crit-
ical care was defined as dependence on ventilator care or 
infusion of inotropes.
Statistical analysis
Statistical analysis was performed using SPSS version 
20.0.0 (IBM Co., Armonk, NY, USA). Continuous vari-
ables were compared by an independent t test after 
normality tests. Not normally distributed continuous 
variables were compared by the Mann-Whitney U test. 
Data are expressed as number (%) or as mean ± standard 
deviation or median (interquartile range). Comparisons 
of categorical data were made using chi-square statistics 
or Fisher exact test. Changes in ECG parameters of each 
patient were compared with the use of generalized-esti-
mating-equation models (for categorical outcomes) and 
repeated measures linear mixed-effects models (for con-
tinuous outcomes). In-hospital mortality was analyzed 
by Kaplan-Meier survival curves, and the differences 
between cumulative in-hospital mortality rates were 
compared with the log rank test. Multivariate logistic 
analysis was performed to determine the independent 
risk factors. The variables with a p < 0.05 in the univari-
ate analysis and traditional cardiac risk factors (age and 
gender) were included in the multivariate regression 
model. A p < 0.05 was considered statistically significant. 
RESULTS
Baseline characteristics of the study population
One hundred and twenty-eight patients were includ-
ed in this study. The patients ranged in age from 15 to 
90 years (mean age, 63.2 ± 15.4), and were 60.9% (78/128) 
female (Table 1). The most common trigger factor of 
SCMP was physical stress (89.1%, 114/128). Pre-existing 
critical illness, such as sepsis, respiratory insufficiency, 
major noncardiac surgery, or cerebrovascular accident, 
were similar be tween two groups. The median time in-
terval from SCMP diagnosis to recovery phase was 13.0 
days (interquartile range [IQR], 7.0 to 32.0) and similar 
in the two groups (15.0 days [IQR, 7.0 to 38.0] in the re-
covered QTc group and 10.0 days [IQR, 7.0 to 23.0] in the 
nonrecovered QTc group, p = 0.199). Pharmacological 
treatment such as β-blocker or calcium channel blocker, 
potentially affecting the QTc interval and the arrhyth-
mogenic risk, were similar between two groups. 
Serial changes of echocardiographic and electrocar-
diographic parameters
Baseline echocardiography of 51 patients and the base-
line ECG of 113 patients were analyzed. Left ventricular 
EF was markedly decreased during the SCMP diagnosis 
phase compared to both baseline and the recovery phase 
(65.5% ± 6.9% vs. 36.1% ± 11.4% vs. 63.6% ± 7.7%, respec-
tively; p < 0.001) (Table 2). Heart rate was also significant-
ly elevated during the SCMP diagnosis phase (81.5 ± 18.7/
min vs. 96.8 ± 25.3/min vs. 83.0 ± 19.4/min, respectively; p 
< 0.001). ST elevation (0.0% vs. 8.6% vs. 1.6%, respective-
ly; p = 0.004) and ST depression (0.0% vs. 6.2% vs. 1.6%, 
respectively; p = 0.007) were more frequently observed 
in the SCMP phase compared to either the baseline or 
recovery phases. However, T wave inversion was more 
frequently observed in the recovery phase than either 
the baseline or SCMP phase (4.4% vs. 43.8% vs. 61.7%, re-
spectively; p < 0.001). The QTc interval was significantly 
prolonged during the SCMP phase (447.4 ± 35.3 ms vs. 
488.9 ± 67.1 ms vs. 468.0 ± 49.5 ms, respectively; p < 0.001), 
and returned to lengths observed in baseline after echo-
cardiography showed recovery of left ventricular systolic 
function. The prevalence of QTc prolongation was also 
more frequently observed in the SCMP phase than the 
other phases (18.6% vs. 56.3% vs. 39.1%, respectively; p < 
0.001).
Comparison of clinical, echocardiographic, and 
electrocardiographic characteristics between recov-
ered vs. nonrecovered QTc group
Even though the average QTc interval returned to base-
line levels for all patients, the simultaneous recovery 
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Table 1. Baseline characteristics
Characteristic Recovered QTc (n = 77) Nonrecovered QTc (n = 51) p value
Age, yr 63.3 ± 14.8 63.1 ± 16.3 0.958
Male sex 29 (37.7) 21 (41.2) 0.690
Body surface area, kg/m2 1.57 ± 0.20 1.58 ± 0.19 0.592
Hypertension 41 (53.2) 19 (37.3) 0.076
Diabetes 18 (23.4) 16 (31.4) 0.316
Dyslipidemia 2 (2.6) 1 (2.0) 0.816
Smoking 17 (22.1) 8 (15.7) 0.372
History of cancer 27 (35.1) 18 (35.3) 0.979
Chronic kidney disease 6 (7.8) 4 (7.8) 0.992
Old cerebrovascular accident 4 (5.2) 4 (7.8) 0.545
Trigger factor 0.411
Emotional stress 7 (9.1) 7 (13.7)
Physical stress 70 (90.9) 44 (86.3)
Sepsis 26 (33.8) 19 (37.3) 0.386
Respiratory insufficiency 20 (26.0) 17 (33.3) 0.369
Major non-cardiac surgery 12 (15.6) 6 (11.8) 0.543
Cerebrovascular accident 4 (5.2) 0 0.098
Systolic blood pressure, mmHg 119.3 ± 17.9 117.3 ± 20.2 0.559
Diastolic blood pressure, mmHg 72.6 ± 13.9 71.8 ± 14.1 0.736
Heart rate, /min 94.5 ± 24.0 103.0 ± 29.0 0.078
Time interval SCMP diagnosis to recovery, day 15 (7–38) 10 (7–23) 0.199
Ejection fraction, %
At baseline 64.8 ± 7.6 66.9 ± 5.4 0.306
At SCMP diagnosed 37.8 ± 11.3 33.5 ± 11.2 0.034
At recovery 63.6 ± 8.0 63.7 ± 7.3 0.934
Wall motion score index
At SCMP diagnosed 2.07 ± 0.31 2.09 ± 0.32 0.675
At recovery 1.04 ± 0.14 1.04 ± 0.13 0.972
Medication
Calcium channel blocker 6 (7.8) 1 (2.0) 0.155
β Blocker 14 (18.2) 6 (11.8) 0.328
ECG parameter
Heart rate, /min
At baseline 80.8 ± 18.5 82.7 ± 19.3 0.610
At SCMP diagnosis 92.3 ± 22.5 103.5 ± 27.9 0.014
At recovery 82.6 ± 20.4 83.7 ± 18.2 0.775
ST elevation
At SCMP diagnosis 8 (10.4) 3 (5.9) 0.373
At recovery 1 (1.3) 1 (2.0) 0.767
ST depression
At SCMP diagnosis 5 (6.5) 3 (5.9) 0.889
At recovery 1 (1.3) 1 (2.0) 0.767
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Table 1. Continued
Characteristic Recovered QTc (n = 77) Nonrecovered QTc (n = 51) p value
T wave inversion
At SCMP diagnosis 38 (49.4) 18 (35.3) 0.117
At recovery 49 (63.6) 30 (58.8) 0.583
QT prolongation
At SCMP diagnosis 62 (80.5) 10 (19.6) < 0.001
At recovery 24 (31.2) 26 (51.0) 0.025
Corrected QT interval, ms
At baseline 449.9 ± 38.0 443.2 ± 30.4 0.322
At SCMP diagnosis 516.9 ± 45.9 456.9 ± 43.8 < 0.001
At recovery 456.3 ± 45.6 485.6 ± 50.3 0.001
Aggravated QTc prolongation (> 500 ms) at SCMP
 diagnosis
49 (63.6) 9 (17.6) < 0.001
Aggravated QTc prolongation (> 500 ms) at recovery 15 (19.5) 17 (33.3) 0.076
Laboratory findings
WBC, count/μL 11,691 ± 7,259 11,174 ± 7,017 0.696
Hemoglobin, g/dL 10.8 ± 2.9 10.8 ± 1.7 0.994
CPK, IU/L 427.3 ± 789.6 332.4 ± 589.3 0.486
CK-MB, ng/mL 14.2 ± 24.3 19.2 ± 40.0 0.387
Troponin-T, ng/mL 0.4 ± 0.7 1.2 ± 5.6 0.314
CRP, mg/L 98.3 ± 100.5 100.6 ± 98.6 0.904
NT-pro BNP, pg/mL 9,558 ± 12,585 6,863 ± 9,072 0.364
Values are presented as mean ± SD, number (%), or median (interquartile range). 
QTc, corrected QT; SCMP, stress-induced cardiomyopathy; WBC, white blood cell; CPK, creatine phosphokinase; CK-MB, cre-
atine kinase MB; CRP, C-reactive protein; NT-pro BNP, N-terminal of the prohormone brain natriuretic peptide.
Table 2. Serial changes of echocardiographic and electrocardiogram parameters during baseline, stress-induced cardiomyop-
athy, and recovery
Echocardiographic parameter Baseline (n = 51) SCMP (n = 128) Recovery (n = 128) p value p valuea p valueb
Ejection fraction, % 65.5 ± 6.9 36.1 ± 11.4 63.6 ± 7.7 < 0.001 < 0.001 < 0.001
Wall motion score index 1.0 ± 0.0 2.1 ± 0.3 1.0 ± 0.1 < 0.001 < 0.001 < 0.001
ECG parameters 113 128 128
Heart rate, /min 81.5 ± 18.7 96.8 ± 25.3 83.0 ± 19.4 < 0.001 < 0.001 < 0.001
Sinus rhythm 104 (92.0) 111 (86.7) 118 (92.2) 0.038 0.030 0.034
Atrial fibrillation 8 (7.1) 12 (9.4) 8 (6.3) 0.256 0.191 0.099
Ventricular premature complex 1 (0.9) 3 (2.3) 2 (1.6) 0.658 0.367 0.654
ST segment elevation 0 11 (8.6) 2 (1.6) 0.004 < 0.001 0.004
ST segment depression 0 8 (6.3) 2 (1.6) 0.007 0.002 0.108
T wave inversion 5 (4.4) 56 (43.8) 79 (61.7) < 0.001 < 0.001 < 0.001
QT interval, ms 390.8 ± 48.1 396.8 ± 82.1 407.3 ± 66.7 0.027 0.904 0.366
Corrected QT interval, ms 447.4 ± 35.3 488.9 ± 67.1 468.0 ± 49.5 < 0.001 < 0.001 0.004
Prolonged QTc 21 (18.6) 72 (56.3) 50 (39.1) < 0.001 < 0.001 0.004
Values are presented as mean ± SD or number (%).
SCMP, stress-induced cardiomyopathy; ECG, electrocardiogram; QTc, corrected QT.
aBaseline vs. SCMP. 
bSCMP vs. recovery. 
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of left ventricular systolic function with an attenuated 
QTc interval was not observed in all patients. Of all the 
patients in this study, 77 patients were categorized into 
the recovered QTc group (QTc in SCMP > QTc in recov-
ery phase) (Fig. 2), and 51 patients were categorized into 
the nonrecovered QTc group (QTc in SCMP ≤ QTc in 
recovery phase) (Fig. 3). The baseline characteristics of 
these two groups were not significantly different (Table 
1). Echocardiography showed that there were no differ-
ences in left ventricular EF at baseline or recovery be-
tween the two groups. However, the nonrecovered QTc 
group showed a lower EF compared to the recovered 
QTc group (33.5% ± 11.2% and 37.8% ± 11.3%, respectively; 
p = 0.034) during the SCMP diagnosis phase. The WMSI 
was 2.08 ± 0.31 when study patients were diagnosed with 
SCMP, and there was no statistical difference between 
two groups, even if their left ventricular systolic func-
tion fully recovered.
The heart rate during the SCMP diagnosis phase of 
the nonrecovered QTc group was faster than that of the 
recovered QTc group (103.5 ± 27.9/min vs. 92.3 ± 22.5/min, 
p = 0.014), but the frequencies of ST elevation, ST de-
pression, and T wave inversion showed no significant 
differences between the two groups. There was a signifi-
cant difference in QTc during both the SCMP diagnosis 
and recovery phases when comparing the recovered and 
nonrecovered QTc group (522.9 ± 53.2 ms vs. 437.7 ±51.9 
ms, p < 0.001 at SCMP diagnosis; 456.3 ± 45.6 ms vs. 485.6 
± 50.3 ms, p = 0.001 at recovery).
Nonrecovered QTc interval is predictor for in-hospi-
tal mortality
There was no difference between two groups with re-
gard to peak creatinine kinase-MB values and the length 
of hospital stay. In-hospital all-cause mortality occurred 
more frequently in the nonrecovered QTc group than in 
the recovered QTc group (25.5% vs. 9.1%, p = 0.012) (Ta-
ble 3, Fig. 4). Severe sepsis and respiratory failure were 
the major causes of death in nonrecovered QTc group 
(17.6% vs. 5.2%, p = 0.022). The incidence of critical care 
was also more frequently observed during hospitaliza-
tion in the nonrecovered QTc group than in the recov-
ered QTc group (72.5% vs. 54.5%, p = 0.040) (Table 3). In 
univariate logistic regression analysis, underlying can-
cer (odds ratio [OR], 2.660; 95% confidence interval [CI], 
1.008 to 7.017; p = 0.048) (Table 4), heart rate at SCMP 
(OR, 1.036; 95% CI, 1.009 to 1.064) and nonrecovered QTc 
(OR, 3.421; 95% CI, 1.258 to 9.301) were associated with in-
Figure 2. The echocardiography and electrocardiogram of 
64-years old male presenting stress-induced cardiomyopa-
thy. He was categorized as the recovered corrected QT (QTc) 
group. (A) The baseline phase, (B) the stress-induced cardio-
myopathy diagnosis phase, (C) the recovery phase. Arrow-
heads indicated the typical apical ballooning. EF, ejection 
fraction; HR, heart rate.
Figure 3. The echocardiography and electrocardiogram of 
89-years old female presenting stress-induced cardiomyop-
athy. She was categorized as the nonrecovered corrected QT 
(QTc) group. (A) The baseline phase, (B) the stress-induced 
cardiomyopathy diagnosis phase, (C) the recovery phase. 
Arrowheads indicated the typical apical ballooning. EF, ejec-
tion fraction; HR, heart rate.
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creased risk of in-hospital mortality. Using multivariate 
logistic regression analysis, the significant determinant 
for in-hospital mortality was nonrecovered QTc (OR, 
3.811; 95% CI, 1.307 to 11.111; p = 0.014), along with heart 
rate as a predictor of in-hospital mortality (OR, 1.039; 
95% CI, 1.009 to 1.070; p = 0.011).
All 20 in-hospital mortality cases occurred upon 
physical stress, and these patients had near complete 
recovery of left ventricular EF. Two of these patients 
had developed sudden cardiac arrest, and it was highly 
suspected that these patients suffered from ventricular 
tachycardia. These patients were also were categorized 
into the nonrecovered QTc group.
DISCUSSION
The major findings of this study are that (1) ECG pa-
rameters of ST segment changes, or QTc interval could 
indicate whether left ventricular dysfunction present at 
the time of SCMP diagnosis was recovered or not, and (2) 
patients whose QTc interval did not recover to baseline 
levels during the SCMP recovery phase had a higher rate 
of in-hospital mortality or critical care. 
Transient changes in the ECG of patients with SCMP 
are commonly observed. A previous study reported the 
time course of these ECG changes and demonstrated a 
deepened T wave inversion and a doubling of the QTc 
interval in SCMP patients [10]. Our findings are con-
sistent with this report. We extended these findings 
by matching ECG parameters with the time course of 
echocardiographic changes when possible. This allowed 
us to demonstrate that both ST elevation or depression 
normalization and T wave inversions co-varied with 
recovery from left ventricular dysfunction. Systolic dys-
function and the regional wall motion abnormalities 
usually return to normal within several weeks [5,6,16]. 
Currently, the recovery of left ventricular dysfunction 
is typically evaluated by echocardiography only, but our 
data suggests that ECG parameters such as ST change, T 
wave properties, or the QTc interval may also be useful 
to help determine if recovery from SCMP has occurred.
In our study, when left ventricular EF had recovered 
Figure 4. Kaplan-Meier for cumulative in-hospital mortality 
incidence (median follow-up duration, 19.5 days; p = 0.012 by 
log-rank). QTc, corrected QT.
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Table 3. Clinical outcomes
Variable Recovered QTc (n = 77) Nonrecovered QTc (n = 51) p value
Peak CK-MB, ng/mL 7.4 (3.3–13.8) 7.6 (3.6–18.1) 0.593
Hospital stay, day 21 (9–37) 19 (9–30) 0.800
Critical carea 42 (54.5) 37 (72.5) 0.040
In-hospital mortality 7 (9.1) 13 (25.5) 0.012
Ventricular arrhythmia 0 2 (3.9) 0.080
Infection or respiratory failure 4 (5.2) 9 (17.6) 0.022
Cancer at terminal stage 3 (3.9) 0 0.154
Values are presented as median (interquartile range) or number (%). 
QTc, corrected QT; CK-MB, creatine kinase MB.
aCritical care was defined as ventilator care or infusion of inotropics.
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in patients with SCMP, we found that 77/128 patients 
(60.2%) presented with a recovered QTc interval, and 
51/128 patients (39.8%) presented with a still prolonged 
QTc interval. Although most of the clinical parameters 
were similar between the two groups, patients in the 
nonrecovered QTc group showed a lower left ventric-
ular EF at the time of SCMP diagnosis and were more 
likely to be associated with in-hospital mortality. While 
a history of cancer was one of the risk factors for in-hos-
pital mortality in univariate analysis, only nonrecovered 
QTc interval was an independent risk factor for in-hos 
pital mortality. Previous report showed that pre-existing 
critical illness, such as sepsis, respiratory insufficiency, 
major noncardiac surgery, or cerebrovascular accident, 
were related with higher in-hospital mortality rate [17]. 
Our study suggested that pre-existing critical illness 
was not sufficient to significantly increased in-hospital 
mortality. We may also consider electrocardiographic 
changes including QTc in patient with SCMP. 
The predictive value of QT dispersion for adverse out-
comes has been evaluated in populations with myocar-
dial infarction, and QT dispersion was demonstrated as 
a predictive factor for malignant ventricular arrhythmia 
[18,19]. Previous studies also demonstrated that the QT 
interval might be influenced by the extent of myocardial 
damage in patients with chronic myocardial infarction 
[20]. A previous report demonstrated that SCMP is rarely 
associated with malignant ventricular arrhythmia, even 
though both a significantly long QT interval and repo-
larization dispersion were observed [9]. However, in 2005 
Denney et al. [11] reported a case of SCMP with QT inter-
val prolongation in a young man who developed torsade 
de pointes and it now can carry a small but significant 
lethal risk for adverse outcomes, including cardiac mor-
tality [21]. Cho et al. [13] also reported a case of SCMP pre-
senting as VT as an initial manifestation. In our study, 
only two of the 20 in-hospital mortality cases (10%) had 
developed sudden cardiac arrest. Both these patients 
suffered from malignant ventricular arrhythmia at the 
time of death, suggesting that this might be one of the 
mechanisms responsible for the observed in-hospital 
mortality. Furthermore, severe form of septic shock 
Table 4. Logistic-regression model for in-hospital mortality
Variable
Univariate analysis Multivariate analysis
OR (95% CI) p value OR (95% CI) p value
Age, /yr 1.013 (0.979–1.047) 0.461 1.006 (0.970–1.044) 0.753
Male sex 1.700 (0.651–4.438) 0.278 1.709 (0.592–4.936) 0.322
Diabetes 1.224 (0.429–3.495) 0.705
Hypertension 0.429 (0.153–1.198) 0.106
Dyslipidemia 2.789 (0.241–32.313) 0.412
Smoking 2.008 (0.684–5.894) 0.205
Underlying cancer 2.660 (1.008–7.017) 0.048 2.301 (0.783–6.762) 0.130
Underlying critical illnessa 5.141 (0.653–40.458) 0.120
Chronic kidney disease 0.579 (0.069–4.840) 0.614
Ejection fraction (%) at SCMP 0.989 (0.947–1.032) 0.598
Heart rate (/min) at SCMP 1.036 (1.009–1.064) 0.008 1.039 (1.009–1.070) 0.011
Aggravated QTc prolongation (> 500 ms) at SCMP 0.985 (0.378–2.570) 0.976
Aggravated QTc prolongation (> 500 ms) at recovery 0.714 (0.220–2.318) 0.575
ST elevation at SCMP 0.516 (0.062–4.269) 0.539
ST depression at SCMP 0.759 (0.088–6.531) 0.802
T inversion at SCMP 1.348 (0.518–3.506) 0.541
Nonrecovered QTc 3.421 (1.258–9.301) 0.016 3.811 (1.307–11.111) 0.014
OR, odds ratio; CI, confidence interval; SCMP, stress-induced cardiomyopathy; QTc, corrected QT.
aCritical illness was defined as a consist of sepsis, respiratory insufficiency, major non-cardiac surgery, or cerebrovascular ac-
cident.
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and respiratory failure were the major causes of death 
in nonrecovered QTc group. It is also hypothesized that 
severe extensive inflammatory reaction accompanying 
catecholamine surge with myocardial dysfunction can 
be related with continued repolarization abnormality.
Although overall in-hospital mortality from SCMP is 
very low, in the subgroup of patients where a physical 
stressor was present, such as illness or major surgery, 
prognosis was worse [4]. A recent study divided patients 
with SCMP into three groups according to ECG abnor-
malities at presentation such as ST elevation, T wave in-
version, or non-specific ST-T abnormalities, but these 
abnormalities did not correlate with clinical outcomes 
[8]. That study categorized three groups according to 
ECG findings present only at SCMP presentation, but 
our study analyzed serial ECG changes during hospi-
talization, and demonstrated that a nonrecovered QTc 
interval was correlated with adverse outcomes. Our 
study is the first study using serial ECG and echocardio-
graphic changes, and our data is the first risk predict-
ing model for patients diagnosed with SCMP. In other 
words, by analyzing several ECG parameters of patient 
with SCMP, we can predict the patient’s clinical phase 
of SCMP and in-hospital outcomes.
This study had several limitations. First, it was a ret-
rospective study based on medical records. Further 
prospective studies are required to examine the signif-
icance of QTc interval changes. Second, we included 
only patients with SCMP who showed fully recovered 
left ventricular EF by echocardiography during the re-
covery phase. This may have potential for selection bias. 
Therefore, these results are only applicable to patients 
with follow-up echocardiography. Third, not all study 
populations performed coronary angiography for the 
purpose of excluding left ventricular dysfunction due to 
coronary artery disease. In our study, only 46 patients 
(35.9%) underwent coronary angiography. However, we 
only included typical apical ballooning that fulfilled 
with Mayo Clinic criteria for SCMP and fully recovered, 
and we excluded patients with possible ischemic heart 
disease. Fourth, not all baseline ECGs or echocardio-
graphic data of each patient were available. However, by 
using linear mixed-effects models and generalized-esti-
mation-equation models, we can analyze all serial ECGs 
and echocardiographic data of each patient.
Some ECG parameters can be a surrogate marker of 
the clinical outcomes of patients presenting with SCMP. 
Even in SCMP patients who had complete recovery of 
left ventricular systolic function, a continued QTc pro-
longation was an independent risk factor for in-hospital 
mortality.
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